- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Authors
Latest:
Language Disparities and Timely Care for Children in Managed Care MedicaidParents with language barriers reported less timely illness care and routine care for children in managed care Medicaid.
Latest:
Cost-effectiveness of Telephonic Disease Management in Heart FailureThis study shows that telephonic disease management was not cost-effective in a broadly representative sample of community-dwelling patients.
Latest:
Improvement of Outpatient Quality Metrics in a Limited-Resource SettingThis study presents an example of a population health initiative in a limited-resource primary care setting that led to significant improvements in preventive care quality metrics in the context of major insurance payers.
Latest:
Changing Trends in Type 2 Diabetes Mellitus Treatment Intensification, 2002-2010Glycemic control can lower the risk of diabetes-related complications, and delayed treatment intensification can impede optimal diabetes care.This study examines trends in hyperglycemia treatment intensification between 2002 and 2010.
Latest:
Patient Experience During a Large Primary Care Practice Transformation InitiativeFour years of practice transformation toward comprehensive primary care had little effect on patient experience.
Latest:
CMS Needs to Address Medicare Underfunding in 2017 Hospital Inpatient Rule for Bone Marrow TransplantationThe Be The Match Registry has seen phenomenal success with bone marrow and umbilical cord transplants. After having overcome donor availability, it is now important for CMS to create standardized reimbursement policies for the procedure.
Latest:
Process of Care Compliance Is Associated With Fewer Diabetes ComplicationsAdherence to process of care measures was associated with reduced risk of 2 diabetes complications or any of 4 complications in a national industrial cohort.
Latest:
Survival and Cost-Effectiveness of Hospice Care for Metastatic Melanoma PatientsHospice care is associated with improved median survival time for the patients diagnosed with metastatic melanoma, accompanied by decreased end-of-life costs.
Latest:
Sofosbuvir Initial Therapy Abandonment and Manufacturer Coupons in a Commercially Insured PopulationMember cost negatively affects initial medication adherence and manufacturer coupons can decrease member share by up to 98%.
Latest:
Understanding the Relationship Between Data Breaches and Hospital Advertising ExpendituresA hospital data breach was associated with a 64% increase in annual advertising expenditures.
Latest:
Telemetry: Appropriateness of Initial Assignment and Duration in Nonintensive SettingThe authors report overutilization of telemetry monitoring in a community setting, increasing the cost of health care and potential harm to patients with unnecessary interventions.
Latest:
Racial and Ethnic Disparity in Palliative Care and Hospice UseRace/ethnicity was not a predictor of inpatient palliative care consultation or discharge to hospice in 4 hospitals with an inpatient palliative care service.
Latest:
Health Economic Analysis of Breast Cancer Index in Patients With ER+, LN- Breast CancerThis study projected that the breast cancer index assay is cost saving when used either at diagnosis or at 5 years post diagnosis.
Latest:
The Value of Novel Immuno-Oncology TreatmentsThis study assesses the value of novel immuno-oncology treatments to society.
Latest:
Efficiency and Its Measurement: What Practitioners Need to KnowStakeholders in US healthcare are increasingly seeking to measure and improve efficiency. This article describes an efficiency concept and some practical measurement challenges.
Latest:
A Narrow View of Choosing WiselyThis letter argues that an editorial published in the August 2018 issue provides an unduly limited perspective of the impact of Choosing Wisely.
Latest:
Who Should We Treat: Elective Surgical Admissions or Patients With COVID-19?In the midst of the coronavirus disease 2019 (COVID-19) pandemic, health care leaders must work to optimize emergency department and hospital efficiency while maintaining patient access to care.
Latest:
Addressing Oncologists' Gaps in the Use of Biosimilar ProductsThe availability of biosimilar products may improve access to healthcare by increasing the number of therapeutic options available at potentially lower costs. As of April 2019, 18 such biological products had been approved by the FDA, including 4 biosimilars for trastuzumab, 3 each for infliximab and adalimumab, 2 each for pegfilgrastim and filgrastim, and 1 each for rituximab, epoetin alfa, bevacizumab, and etanercept. The pace of approvals has accelerated, from the first indication for a filgrastim biosimilar in 2015 to 3 approvals in 2016, 5 in 2017, and 9 through early 2019, 7 of which were announced in the 2018 calendar year.
Latest:
Health Information Exchange and the Frequency of Repeat Medical ImagingUsage of a health information exchange system at the point of care reduced the occurrence of repeat imaging procedures in a multi-payer community sample.
Latest:
Dialing In: Effect of Telephonic Wellness Coaching on Weight LossSmall weight loss was reported by overweight/obese individuals targeted for telephonic wellness coaching in this large retrospective study using pre-post design.
Latest:
Comparison of Healthcare Utilization Among Patients Treated With Alcoholism MedicationsTreatment of alcohol dependence with medications offered advantages in reduced healthcare utilization and costs compared with usual treatment without medications.
